The German SCHOTT Group adds manufacturing of prefillable glass syringes (PFS) in Lukácsháza to its Hungary portfolio. The EUR 76 million investment to be completed by 2024 will create 120 new jobs and is bound to address global demand for the product concerned. 12% of the costs are borne by Hungarian taxpayers through a government decision.
Mainz-based SCHOTT produces special glassware, glass ceramics and related high-end material, with its Hungarian subsidiary, SCHOTT Hungary Kft. being the largest pharmaceutical manufacturing plant of the Group.
By using cutting-edge technology, syringes can be prefilled with medication in the case of drugs to be administered which simplifies the injection process and increases dosing accuracy.
High-quality prefillable syringes are designed to ease the administration process, ultimately enhancing patient safety. Our products are used to safely store a wide range of drugs, including vaccines and biologics, highlights Christian Helbig, Head of Glass Syringes at SCHOTT’s Pharma business unit.
As part of the company’s global production network in 13 countries, the new production line planned for Lukácsháza will follow high-end processes and advanced quality assurance.
Top 5 Articles
Duna House Profit Climbs Nearly 70% in Q3 November 24, 2025 
What Awaits the Hungarian Economy in 2026 and 2027? April 24, 2026 
'Recharge' Campaign Launched to Boost Domestic Tourism January 21, 2026 
Richter Earnings Slip as Financial Loss Weighs November 6, 2025 
Genius Automotive Hungarian Subsidiary's CEE Expansion November 2, 2025
